Preliminary results from PiSARRO, a phase Ib/II study of APR-246, a mutant p53 reactivating small molecule, in combination with standard chemotherapy in platinum-sensitive ovarian cancer



von Euler, Mikael, Wiman, Klas G, Gabra, Hani, Brenton, James D, Basu, Bristi, Vergote, Ignace, Gourley, Charlie, Smith, Austin, Alfredsson, Jessica, Mohelll, Nina
et al (show 1 more authors) (2015) Preliminary results from PiSARRO, a phase Ib/II study of APR-246, a mutant p53 reactivating small molecule, in combination with standard chemotherapy in platinum-sensitive ovarian cancer. .

[img] Text
aacr poster JAG.docx - Accepted Version

Download (383kB)
Item Type: Conference or Workshop Item (Unspecified)
Depositing User: Symplectic Admin
Date Deposited: 19 Jul 2016 10:18
Last Modified: 09 Jan 2021 08:20
DOI: 10.1158/1538-7445.AM2015-CT204
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3002415